RNActive-derived Prostate Cancer Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RNActive-derived Prostate Cancer Vaccine, covering 2017-02-17 to 2018-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease [Phase 1, Phase 2]